Citius Oncology (CTOR) Total Liabilities (2021 - 2026)

Citius Oncology's Total Liabilities history runs 6 years deep, the most recent figure standing at $65.4 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 17.27% year-over-year to $65.4 million; the TTM figure through Mar 2026 stood at $65.4 million (up 17.27% YoY), while the FY2025 annual figure was $56.1 million, up 46.69% from the prior year.
• Total Liabilities was $65.4 million for Q1 2026 at Citius Oncology, up from $51.6 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $69.9 million in Q2 2023 to a low of -$36.0 million in Q3 2022.
• Historically, Total Liabilities has averaged $45.3 million across 5 years, with a median of $51.6 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Total Liabilities surged 49590.45% in 2022, then plunged 57.98% in 2024.
• A 5-year view of Total Liabilities shows it stood at $67.8 million in 2022, then declined by 26.45% to $49.9 million in 2023, then dropped by 1.42% to $49.2 million in 2024, then advanced by 4.81% to $51.6 million in 2025, then advanced by 26.9% to $65.4 million in 2026.
• The last three Total Liabilities figures came in at $65.4 million (Q1 2026), $51.6 million (Q4 2025), and $56.1 million (Q3 2025), per Business Quant data.